Acrux is an Australian drug delivery specialist focused on developing transdermal pharmaceutical products. It uses proprietary transdermal technology to develop new formulations of established drugs, bringing clinical and product life cycle management benefits. Former licensee partner Eli Lilly marketed lead product Axiron for low testosterone levels in a number of countries, including the United States. Other marketed products include Evamist spray (for menopause-related symptoms) and Recuvyra (for postoperative pain management in dogs).